Can We Talk? US FDA Remote Records Review Missteps Worry Industry
Executive Summary
Alkermes CRL is just the latest fallout from black-hole process.
You may also be interested in...
What Congress Could Do About Remote US FDA Inspections That Are Not Inspections
Now that video site tours can sidestep pandemic travel restrictions, an expert who consults for industry on US FDA inspections suggests Congress may want to revise the FD&C Act to sidestep the “site entry” inspections limitation.
Remote Methods Drove Most US FDA Enforcement Actions In FY 2021
Product sampling and remote records requests accounted for most import alerts and drug GMP warning letters over the past year – and may play key role post-pandemic.
Alkermes CEO Appeals To US FDA’s Woodcock In ‘COVID-19 Pandemic And Depression’ Meeting
Richard Pops has publicly complained about the agency’s review performance during COVID, and Alkermes’ application for a mental health product appears to have been held up because of inspection issues.